This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Social Bookmarking   What's this?

Rita Yuval, BA, RN; David A. Halon, MB, ChB; Amnon Merdler, MD; Nader Khader, MD; Basheer Karkabi, MD; Klari Uziel; Basil S. Lewis, MD, FRCP

Arch Intern Med. 2000;160:1142-1146.

Background  Although randomized clinical trials are currently the standard for the evaluation of new therapeutic strategies, little attention has been paid to the viewpoint of the patients recruited to these trials.

Objective  To examine the perspective of the Israeli patient cohort who participated in the Fourth International Study of Infarct Survival, a randomized trial in acute myocardial infarction.

Methods  A patient questionnaire was mailed to 360 Israeli patients who participated in the Fourth International Study of Infarct Survival and was returned by 150 of them. Main outcome measures included patient perception of consent procedures, comprehension of the study, subjective reaction to participating in the trial, and interest in present and future trials.

Results  Forty (31%) of 129 patients perceived that they had full comprehension of the trial, while 64 (50%) claimed partial understanding and 25 (19%), no understanding at all. Comprehension was related to a recollected explanation of 5 minutes or more (P<.001) and to an opportunity for discussion at the time of consent (P<.001). Most patients recollected the oral explanation; fewer, the written material. Patient consent was given by 64 (43%) of 150 patients in the hope of better treatment. In 36 cases (25%), the patients felt they received better treatment because of participation in the trial.

Conclusions  Despite proper attention to accepted ethical and legal standards, perceived patient comprehension in this trial in acute myocardial infarction was incomplete or lacking in a considerable number of subjects. Much progress must be made toward the goal of true informed consent in clinical trials.

From the Cardiovascular Clinical Trials Unit, Department of Cardiology, Lady Davis Carmel Medical Center (Ms Yuval and Drs Halon, Merdler, Khader, Karkabi, and Lewis and Ms Uziel), and the Bruce Rappaport School of Medicine (Drs Halon and Lewis), Technion–Israel Institute of Technology, Haifa, Israel.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(8):1206-1207.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ethical Issues in Cardiovascular Research Involving Humans
Frye et al.
Circulation 2009;120:2113-2121.
FULL TEXT  

Why Patients Continue to Participate in Clinical Research
Wendler et al.
Arch Intern Med 2008;168:1294-1299.
ABSTRACT | FULL TEXT  

Medical Informed Consent: General Considerations for Physicians
Paterick et al.
Mayo Clin Proc. 2008;83:313-319.
ABSTRACT | FULL TEXT  

Consent for Intravenous Thrombolysis in Acute Stroke: Review and Future Directions
White-Bateman et al.
Arch Neurol 2007;64:785-792.
ABSTRACT | FULL TEXT  

Is informed consent possible in acute myocardial infarction?
Foex
Heart 2004;90:1237-1238.
FULL TEXT  

Patients' perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial
Gammelgaard et al.
Heart 2004;90:1124-1128.
ABSTRACT | FULL TEXT  

Obtaining informed consent from patients in the early phase of acute myocardial infarction: physicians' experiences and attitudes
Agard et al.
Heart 2004;90:208-210.
FULL TEXT  

Premature stopping and informed consent in AMI trials
Hilden and Gammelgaard
J. Med. Ethics 2002;28:188-189.
ABSTRACT | FULL TEXT  

Patients' experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient's capacity?
Agard et al.
Heart 2001;86:632-637.
ABSTRACT | FULL TEXT  

Perceived benefit after participating in positive or negative / neutral heart failure trials: the patients' perspective
Yuval et al.
Eur J Heart Fail 2001;3:217-223.
ABSTRACT | FULL TEXT  

Patients' Point of View in Heart Failure Trials
Yuval et al.
JAMA 2001;285:883-884.
FULL TEXT